Cellular damage caused by reactive oxygen species (ROS) is believed to be a major contributor to the onset of detrimental diseases associated with aging. Among eukaryotes, the Nrf2 family transcription factors are conserved and act as the master regulators of the antioxidant response for protection against stress. SKN-1, a C. elegans ortholog of Nrf2, plays a crucial role in various aspects of organismal development, longevity and stress resistance. However, the molecular mechanisms of SKN-1 and its upstream regulation are poorly understood. Our lab previously introduced the C. elegans BRCA1 associated binding protein 2, BRAP-2, and discovered that
brap-2 mutant worms arrest at L1 larval stage when exposed to oxidative stress. We have used both genetics and biochemical approaches to determine how BRAP-2 regulates SKN-1 and its target stress genes. Here we show that the
brap-2(
ok1492) mutation enhances the expression of
skn-1 dependent gene
gst-4 in the intestine and hypodermis, indicating that the presence of BRAP-2 may act as a potential inhibitor of SKN-1. Furthermore, the loss of BRAP-2 increases p-MAPK protein levels, and BRAP-2 physically interacts with LET-60/Ras and KSR-1/2. These results suggest that the ERK/MAPK pathway is involved in BRAP-2/SKN-1 regulation.To better define the BRAP-2/SKN-1 signaling cascade, we used reverse genetics to identify twenty novel transcription factors or co-activators of SKN-1 that elevate
gst-4 expression in the
brap-2(
ok1492) mutant. The screen identified
elt-3 as a potential candidate, and our results show that ELT-3/GATA is required for enhanced
gst-4 expression in the
brap-2(
ok1492) mutant, through binding to SKN-1. Further analysis revealed that the activation of
gst-4 by SKN-1 requires ELT-3, indicating that they may dimerize to increase
gst-4 transcriptional activity. Lastly, we have observed that extended lifespan in overexpressing SKN-1 is dependent on functional ELT-3. Together, this suggests a new role for BRAP-2 in the regulation of the SKN-1/ELT-3 complex in response to oxidative stress through the ERK/MAPK pathway.